ClinConnect ClinConnect Logo
Search / Trial NCT06614491

SCOPE - Single-Point Classification Observational Peristomal Evaluation

Launched by CONVATEC INC. · Sep 24, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The SCOPE trial is a study designed to better understand skin health around ostomies, which are openings created in the body for waste removal, including ileostomies, colostomies, and urostomies. Researchers will collect photos of these stomas (the part of the body where the waste comes out) to compare the images and evaluate skin conditions digitally instead of just through in-person visits. This could help improve care for people with ostomies.

To be eligible for this study, participants must be at least 18 years old and have an ileostomy, colostomy, or urostomy. They also need to be willing to provide consent to participate. However, individuals with two or more ostomies or specific complications related to their stomas, like enterocutaneous fistulae, won't be able to join. Although the study is not yet recruiting participants, it aims to gather important information that could lead to better management and care for people with these types of surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with ileostomy, colostomy or urostomy
  • Age ≥ 18 years of age
  • Able and willing to provide informed consent
  • Exclusion Criteria:
  • Enterocutaneous fistulae
  • Patients with two or more ostomies

About Convatec Inc.

ConvaTec Inc. is a global medical technology company dedicated to the development and commercialization of innovative products and solutions for the management of chronic and acute medical conditions. With a focus on advanced wound care, ostomy care, continence and critical care, and infusion devices, ConvaTec aims to enhance the quality of life for patients through evidence-based practices and cutting-edge research. The company is committed to clinical excellence and actively sponsors clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of healthcare delivery and patient outcomes.

Locations

Bogotá, , Colombia

Medellín, , Colombia

São Paulo, , Brazil

São Paulo, , Brazil

Bogotá, , Colombia

Medellín, , Colombia

Patients applied

0 patients applied

Trial Officials

Sandra Guerrero, MD

Principal Investigator

Principal Investigator Colombia

Maria Angela Boccara de Paula, PhD

Principal Investigator

Principal Investigator Brazil

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported